Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Medical Isotope Market, by Type
1.4.2 Europe Medical Isotope Market, by End User
1.4.3 Europe Medical Isotope Market, by Application
1.4.4 Europe Medical Isotope Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Recent Strategies Deployed in Medical Isotopes Market
Chapter 5. Europe Medical Isotope Market by Type
5.1 Europe Radioisotopes Market by Country
5.2 Europe Stable Isotopes Market by Country
Chapter 6. Europe Medical Isotope Market by End User
6.1 Europe Hospitals Market by Country
6.2 Europe Diagnostic Centers Market by Country
6.3 Europe Research Institutes Market by Country
Chapter 7. Europe Medical Isotope Market by Application
7.1 Europe Diagonostic Market by Country
7.2 Europe Nuclear Therapy Market by Country
Chapter 8. Europe Medical Isotope Market by Country
8.1 Germany Medical Isotope Market
8.1.1 Germany Medical Isotope Market by Type
8.1.2 Germany Medical Isotope Market by End User
8.1.3 Germany Medical Isotope Market by Application
8.2 UK Medical Isotope Market
8.2.1 UK Medical Isotope Market by Type
8.2.2 UK Medical Isotope Market by End User
8.2.3 UK Medical Isotope Market by Application
8.3 France Medical Isotope Market
8.3.1 France Medical Isotope Market by Type
8.3.2 France Medical Isotope Market by End User
8.3.3 France Medical Isotope Market by Application
8.4 Russia Medical Isotope Market
8.4.1 Russia Medical Isotope Market by Type
8.4.2 Russia Medical Isotope Market by End User
8.4.3 Russia Medical Isotope Market by Application
8.5 Spain Medical Isotope Market
8.5.1 Spain Medical Isotope Market by Type
8.5.2 Spain Medical Isotope Market by End User
8.5.3 Spain Medical Isotope Market by Application
8.6 Italy Medical Isotope Market
8.6.1 Italy Medical Isotope Market by Type
8.6.2 Italy Medical Isotope Market by End User
8.6.3 Italy Medical Isotope Market by Application
8.7 Rest of Europe Medical Isotope Market
8.7.1 Rest of Europe Medical Isotope Market by Type
8.7.2 Rest of Europe Medical Isotope Market by End User
8.7.3 Rest of Europe Medical Isotope Market by Application
Chapter 9. Company Profiles
9.1 Canadian Nuclear Laboratories (Atomic Energy of Canada Limited)
9.1.1 Company Overview
9.1.2 Recent strategies and developments:
9.1.2.1 Partnerships, Collaborations, and Agreements:
9.1.3 SWOT Analysis
9.2 ITM Isotope Technologies Munich SE
9.2.1 Company Overview
9.2.2 Recent strategies and developments:
9.2.2.1 Partnerships, Collaborations, and Agreements:
9.2.3 SWOT Analysis
9.3 ECZACIBAŞI-MONROL
9.3.1 Company Overview
9.3.2 Recent strategies and developments:
9.3.2.1 Partnerships, Collaborations, and Agreements:
9.3.3 SWOT Analysis
9.4 NorthStar Medical Radioisotopes, LLC
9.4.1 Company Overview
9.4.2 Recent strategies and developments:
9.4.2.1 Partnerships, Collaborations, and Agreements:
9.4.3 SWOT Analysis
9.5 Iba SA
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 SWOT Analysis
9.6 Mallinckrodt PLC
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 SWOT Analysis
9.7 GE HealthCare Technologies, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.6 SWOT Analysis
9.8 Nordion Inc. (Sotera Health LLC)
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.9 Bayer AG
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.6 SWOT Analysis
9.10. Siemens Healthineers AG (Siemens AG)
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expense
9.10.5 SWOT Analysis
Unique Offerings 